You have 9 free searches left this month | for more free features.

Condition

Antibody-mediated Rejection (1)

Immunoglobulin A (IgA) Nephropathy (1)

Lupus Nephritis (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Farsad Eskandary (1)

HI-Bio (1)

MorphoSys AG (1)

Collaborator

Charite University, Berlin, Germany (1)

MorphoSys AG (1)

University of Alberta (1)

Intervention

felzartamab (3)

placebo (2)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

felzartamab

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lupus Nephritis Trial (Felzartamab)

Not yet recruiting

Lupus Nephritis

Felzartamab

(no location specified)

Sep 26, 2023

Antibody-mediated Rejection Trial in Vienna, Berlin (Felzartamab, Placebo)

Recruiting

Antibody-mediated Rejection

Felzartamab
Placebo

Vienna, Austria
+1 more

Aug 23, 2022

Immunoglobulin A (IgA) Nephropathy Trial in Worldwide (Felzartamab, Placebo)

Recruiting

Immunoglobulin A (IgA) Nephropathy

Felzartamab
Placebo

Oxnard, California
+59 more

Dec 12, 2022